Search

everythinglearnresearchcommunity

for

Search:↓

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Nail loss may be a side effect of the MS drug teriflunomide.

Baricitinib successfully treated severe hair loss.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

A baby girl's severe scalp infection caused by a fungus was cured with oral and topical antifungal medications.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Tirzepatide may improve hair loss by reducing insulin resistance.

Methotrexate plus prednisolone had the fewest serious side effects.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.